Press Releases Marinomed Biotech AG

Equities

MARI

ATMARINOMED6

Market Closed - Wiener Boerse Other stock markets 09:05:15 15/05/2024 pm IST			5-day change	1st Jan Change
16.7 ^EUR	-1.47%		-2.34%	-42.81%

16/04	Transcript : Marinomed Biotech AG, 2023 Earnings Call, Apr 16, 2024
16/04	Marinomed Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios	25/04	EQ
AFR: Marinomed Biotech AG: Release of a Financial report	16/04	EQ
Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets	16/04	EQ
AFR: Marinomed Biotech AG: Release of a Financial report	16/04	EQ
Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution	15/04	EQ
Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico	11/04	EQ
Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months	28/03	EQ
Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe	26/03	EQ
Marinomed Biotech AG: Lucia Ziegler new Head of Investor & Public Relations	01/03	EQ
Marinomed Biotech AG announces preliminary revenue for 2023	14/02	EQ
Marinomed Biotech AG with important progress for Carragelose in 2024	07/02	EQ
Marinomed Biotech AG evaluates strategic options for Carragelose portfolio	18/12	EQ
Marinomed Biotech AG evaluates strategic options for Carragelose portfolio	18/12	EQ
Marinomed Biotech AG with new Carragelose distribution and manufacturing partners and EU patent	14/12	EQ
Marinomed Biotech AG: Stable revenues in the first three quarters of 2023 and further progress in business development	21/11	EQ
Marinomed Biotech AG resumes Nice & Green Convertible Notes Funding Program with reduced volume	17/23/17	EQ
Marinomed Biotech AG reports record revenues in the first half of the year and pushes business development activities	17/23/17	EQ
Marinomed enters first long-term Solv4U partnership with Shanghaibased SPH Sine Pharmaceutical Laboratories Co. Ltd.	09/23/09	EQ
Marinomed Biotech AG: M8 Pharmaceuticals obtains market authorization for Carragelose nasal spray in Mexico	27/23/27	EQ
Peer-reviewed publication by Marinomed Biotech AG and Friedrich-Alexander-University Erlangen-Nürnberg reconfirms broad virus-blocking effectiveness of iota-carrageenan	13/23/13	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Marinomed Biotech AG

Equities

MARI

ATMARINOMED6

Press Releases

Filters